Leo Lee

Leo Lee is an experienced professional in the pharmaceutical and biotechnology industries with a strong focus on medical affairs, clinical development, and regulatory compliance. Currently serving as a Senior Manager in Pharmacovigilance Compliance at Genentech since January 2018, Leo Lee previously held roles at Amgen where responsibilities included overseeing the global clinical development of Kyprolis for multiple myeloma and managing investigator-initiated oncology research programs. Earlier experience with Pfizer involved project management for the development of drug candidates and collaboration across functions. Leo Lee began a career as a scientist and project manager at Genset Corporation and Clonetics, specializing in research and assay development. Academically, Leo Lee holds a Bachelor of Science in Biochemistry and Cell Biology from UC San Diego, a Master of Science in Toxicology from San Diego State University, and an MBA in Business Management from the University of San Diego.